{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:20:16Z","timestamp":1794522016046,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260573"],"award-info":[{"award-number":["82260573"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Major Special Science and Technology Project","award":["2017ZX10203207"],"award-info":[{"award-number":["2017ZX10203207"]}]},{"name":"High-level innovation team and outstanding scholar program in Guangxi Colleges and Universities, \u201c139\u201d projects for training high-level medical science talents from Guangxi","award":["G201903001"],"award-info":[{"award-number":["G201903001"]}]},{"name":"The Key Research and Development Project of Guangxi","award":["AB20297009, AA18221001, AB18050020"],"award-info":[{"award-number":["AB20297009, AA18221001, AB18050020"]}]},{"name":"The Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumor, Ministry of Education\/Guangxi, Independent Research Project","award":["GKE2017-ZZ02, GKE2018-KF02, GKE2019-ZZ07"],"award-info":[{"award-number":["GKE2017-ZZ02, GKE2018-KF02, GKE2019-ZZ07"]}]},{"name":"Development and application of medical and health appropriate technology in Guangxi","award":["S2019039"],"award-info":[{"award-number":["S2019039"]}]},{"DOI":"10.13039\/501100012543","name":"Youth Science Foundation of Guangxi Medical University","doi-asserted-by":"publisher","award":["GXMUYSF202321"],"award-info":[{"award-number":["GXMUYSF202321"]}],"id":[{"id":"10.13039\/501100012543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Self-funded Scientific Research Project of the Health and Family Planning Commission of Guangxi Zhuang Autonomous Region","award":["Z-A20240412"],"award-info":[{"award-number":["Z-A20240412"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03112-4","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T14:45:14Z","timestamp":1771771514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Triglyceride glucose index\u2014a body shape index (TyG-ABSI) outperforms traditional obesity indices in predicting all-cause and cardiovascular mortality in metabolic-dysfunction associated steatotic liver disease: the mediating role of biological aging"],"prefix":"10.1186","volume":"25","author":[{"given":"Guodong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangde","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"issue":"3","key":"3112_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical","year":"2024","unstructured":"EASL-EASD-EASO Clinical. Practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","journal-title":"J Hepatol"},{"key":"3112_CR2","doi-asserted-by":"crossref","unstructured":"Driessen S et al. Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology. 2025;82(2):487\u2013503.","DOI":"10.1097\/HEP.0000000000000735"},{"issue":"4","key":"3112_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"12","key":"3112_CR4","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.jhepr.2024.101193","volume":"6","author":"J Pustjens","year":"2024","unstructured":"Pustjens J et al. Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD. JHEP Rep. 2024;6(12):101193.","journal-title":"JHEP Rep"},{"issue":"62","key":"3112_CR5","first-page":"pe70087","volume":"2025","author":"H Zeng","year":"2020","unstructured":"Zeng H et al. Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population-based study. MedComm. 2020;2025(62):pe70087.","journal-title":"MedComm"},{"issue":"Suppl","key":"3112_CR6","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"3112_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"1","key":"3112_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12933-025-02941-z","volume":"24","author":"M Gan","year":"2025","unstructured":"Gan M et al. Association between atherogenic index of plasma (AIP) and all-cause and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a cohort study based on NHANES 1999\u20132018. Cardiovasc Diabetol. 2025;24(1):391.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2024;23(1):243.","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 1","key":"3112_CR10","first-page":"S10","volume":"59","author":"SK Bansal","year":"2024","unstructured":"Bansal SK, Bansal MB. Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024;59(Suppl 1):S10\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3112_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P et al. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","volume":"24","author":"X Gao","year":"2025","unstructured":"Gao X et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2025;24(1):200.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3112_CR16","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.1371\/journal.pone.0039504","volume":"7","author":"NY Krakauer","year":"2012","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7):e39504.","journal-title":"PLoS ONE"},{"issue":"1","key":"3112_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12933-025-02604-z","volume":"24","author":"H He","year":"2025","unstructured":"He H et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24(1):69.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12933-025-02921-3","volume":"24","author":"M Chen","year":"2025","unstructured":"Chen M et al. Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0\u20133: findings from two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):366.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR19","doi-asserted-by":"publisher","first-page":"37276","DOI":"10.1038\/s41598-025-21331-9","volume":"15","author":"Z Li","year":"2025","unstructured":"Li Z et al. Joint association of triglyceride-glucose index and obesity indicators with stroke risk: a nationwide prospective cohort study. Sci Rep. 2025;15(1):37276.","journal-title":"Sci Rep"},{"issue":"6","key":"3112_CR20","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"5","key":"3112_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM et al. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80(5):694\u2013701.","journal-title":"J Hepatol"},{"key":"3112_CR22","doi-asserted-by":"publisher","first-page":"1534604","DOI":"10.3389\/fnut.2025.1534604","volume":"12","author":"X Qiu","year":"2025","unstructured":"Qiu X et al. Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study. Front Nutr. 2025;12:1534604.","journal-title":"Front Nutr"},{"issue":"1","key":"3112_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12933-025-03021-y","volume":"24","author":"X Shao","year":"2025","unstructured":"Shao X et al. Association between triglyceride-glucose index combined with a body shape index and atherosclerotic cardiovascular disease risk varies by glycemic status: insights from the UK biobank. Cardiovasc Diabetol. 2025;24(1):456.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3112_CR24","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s11357-021-00480-5","volume":"43","author":"D Kwon","year":"2021","unstructured":"Kwon D, Belsky DW. A toolkit for quantification of biological age from blood chemistry and organ function test data: bioage. Geroscience. 2021;43(6):2795\u2013808.","journal-title":"Geroscience"},{"issue":"1","key":"3112_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/0081175012444861","volume":"42","author":"KB Karlson","year":"2012","unstructured":"Karlson KB, Holm A, Breen R. Comparing regression coefficients between same-sample nested models using logit and probit: A new method. Sociol Methodol. 2012;42(1):286\u2013313.","journal-title":"Sociol Methodol"},{"issue":"2","key":"3112_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3200\/GENP.136.2.153-178","volume":"136","author":"LA Gelfand","year":"2009","unstructured":"Gelfand LA, Mensinger JL, Tenhave T. Mediation analysis: a retrospective snapshot of practice and more recent directions. J Gen Psychol. 2009;136(2):153\u201376.","journal-title":"J Gen Psychol"},{"issue":"1","key":"3112_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ. Mediation analysis: a practitioner\u2019s guide. Annu Rev Public Health. 2016;37(1):17\u201332.","journal-title":"Annu Rev Public Health"},{"key":"3112_CR28","doi-asserted-by":"publisher","first-page":"1136284","DOI":"10.3389\/fnut.2023.1136284","volume":"10","author":"F Shen","year":"2023","unstructured":"Shen F et al. Non-insulin-based insulin resistance indices for predicting all-cause mortality and renal outcomes in patients with stage 1\u20134 chronic kidney disease: another paradox. Front Nutr. 2023;10:1136284.","journal-title":"Front Nutr"},{"key":"3112_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41512-018-0037-2","volume":"2","author":"NR Cook","year":"2018","unstructured":"Cook NR. Quantifying the added value of new biomarkers: how and how not. Diagn Progn Res. 2018;2:14.","journal-title":"Diagn Progn Res"},{"issue":"1","key":"3112_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C et al. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"L Tao","year":"2022","unstructured":"Tao L et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12944-024-02277-9","volume":"23","author":"Y Chen","year":"2024","unstructured":"Chen Y et al. The association between triglyceride-glucose index and its combination with systemic inflammation indicators and all-cause and cardiovascular mortality in the general US population: NHANES 1999\u20132018. Lipids Health Dis. 2024;23(1):289.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3112_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J et al. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12933-024-02308-w","volume":"23","author":"Z Zhou","year":"2024","unstructured":"Zhou Z et al. Comparative study on the predictive value of TG\/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study. Cardiovasc Diabetol. 2024;23(1):213.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3112_CR35","first-page":"535","volume":"18","author":"CM Prado","year":"2015","unstructured":"Prado CM, Gonzalez MC, Heymsfield SB. Body composition phenotypes and obesity paradox. Curr Opin Clin Nutr Metab Care. 2015;18(6):535\u201351.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3112_CR36","doi-asserted-by":"crossref","unstructured":"Nagayama D et al. A body shape index (ABSI) as a variant of conicity index not affected by the obesity paradox: A Cross-Sectional study using arterial stiffness parameter. J Pers Med. 2022;12(12):2014.","DOI":"10.3390\/jpm12122014"},{"issue":"1","key":"3112_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12933-025-02902-6","volume":"24","author":"X Zheng","year":"2025","unstructured":"Zheng X et al. Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES. Cardiovasc Diabetol. 2025;24(1):344.","journal-title":"Cardiovasc Diabetol"},{"key":"3112_CR38","doi-asserted-by":"publisher","first-page":"115468","DOI":"10.1016\/j.socscimed.2022.115468","volume":"314","author":"Y Li","year":"2022","unstructured":"Li Y et al. The impact of lifestyle guidance intervention on health outcomes among Japanese middle-aged population with metabolic syndrome: A regression discontinuity study. Soc Sci Med. 2022;314:115468.","journal-title":"Soc Sci Med"},{"issue":"4","key":"3112_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.tcm.2019.05.012","volume":"30","author":"DS Dhindsa","year":"2020","unstructured":"Dhindsa DS, et al. Marital status and outcomes in patients with cardiovascular disease. Trends Cardiovasc Med. 2020;30(4):215\u201320.","journal-title":"Trends Cardiovasc Med"},{"key":"3112_CR40","unstructured":"Schultz WM et al. Marital status and outcomes in patients with cardiovascular disease. J Am Heart Assoc. 2017;6(12):e005890."},{"issue":"9","key":"3112_CR41","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.numecd.2023.05.016","volume":"33","author":"W Zhou","year":"2023","unstructured":"Zhou W et al. A body shape index is positively associated with all-cause and cardiovascular disease mortality in the Chinese population with normal weight: A prospective cohort study. Nutr Metab Cardiovasc Dis. 2023;33(9):1702\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"3112_CR42","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371.","journal-title":"Cell"},{"issue":"7121","key":"3112_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"J Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s J, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881\u20137.","journal-title":"Nature"},{"key":"3112_CR44","doi-asserted-by":"publisher","first-page":"104458","DOI":"10.1016\/j.ebiom.2023.104458","volume":"89","author":"L Chen","year":"2023","unstructured":"Chen L et al. Modeling biological age using blood biomarkers and physical measurements in Chinese adults. EBioMedicine. 2023;89:104458.","journal-title":"EBioMedicine"},{"issue":"1","key":"3112_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-025-02631-w","volume":"24","author":"L Pan","year":"2025","unstructured":"Pan L, Jin L. Association between triglyceride glucose index and biological aging in U.S. Adults: National health and nutrition examination survey. Cardiovasc Diabetol. 2025;24(1):100.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3112_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12933-025-02770-0","volume":"24","author":"L Hu","year":"2025","unstructured":"Hu L et al. How does biological age acceleration mediate the associations of obesity with cardiovascular disease? Evidence from international multi-cohort studies. Cardiovasc Diabetol. 2025;24(1):209.","journal-title":"Cardiovasc Diabetol"},{"key":"3112_CR47","doi-asserted-by":"publisher","first-page":"105785","DOI":"10.1016\/j.archger.2025.105785","volume":"132","author":"X Zhu","year":"2025","unstructured":"Zhu X et al. Association between biological aging and cardiovascular health: combined evidence based on cross-sectional and prospective study. Arch Gerontol Geriatr. 2025;132:105785.","journal-title":"Arch Gerontol Geriatr"},{"key":"3112_CR48","doi-asserted-by":"crossref","unstructured":"Dzi\u0119gielewska-G\u0119siak S, Muc-Wierzgo\u0144 M. Inflammation and oxidative stress in frailty and metabolic Syndromes-Two sides of the same coin. Metabolites 2023;13(4):475.","DOI":"10.3390\/metabo13040475"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03112-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:02:26Z","timestamp":1774663346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03112-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3112"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03112-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. NHANES database was conducted with approval by the National Center for Health Statistics Ethics Review Board, and obtained informed written consent from all the individuals involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}